Is Big Pharma Doing Enough to Develop Treatments For The Crisis?

The unique needs of an ongoing opioid crisis have pushed researchers to innovate while developing approaches to treat substance use disorders. Despite the increasing investment and public interest, big pharma remains apprehensive about leading the way for the development of new treatments in the backdrop of lawsuits for its alleged role in fueling the epidemic.

https://www.pharmaceutical-technology.com/analysis/the-opioid-epidemic-is-pharma-doing-enough-to-develop-treatments-for-the-crisis/